CRISPR Therapeutics AG (CRSP) Current Taxes (2015 - 2026)

CRISPR Therapeutics AG has disclosed Current Taxes across 12 years of filings, most recently posting $494000.0 for Q2 2026.

• In Q2 2026, Current Taxes fell 30.91% year-over-year to $494000.0; the TTM figure through Jun 2026 stood at $494000.0 (down 30.91% YoY), while the FY2025 annual figure was $1.1 million, up 146.78% from the prior year.
• Current Taxes came in at $494000.0 for Q2 2026 at CRISPR Therapeutics AG, down from $638000.0 in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $4.3 million in Q3 2022 to a low of $135000.0 in Q4 2022.
• Average Current Taxes over 5 years is $1.3 million, with a median of $676500.0 recorded in 2025.
• Year-over-year, Current Taxes slumped 95.88% in 2023 and surged 376.14% in 2024.
• Over 5 years, Current Taxes stood at $135000.0 in 2022, then jumped by 224.44% to $438000.0 in 2023, then grew by 2.97% to $451000.0 in 2024, then surged by 146.78% to $1.1 million in 2025, then slumped by 55.62% to $494000.0 in 2026.
• Per Business Quant data, the three most recent Current Taxes figures were $494000.0 in Q2 2026, $638000.0 in Q1 2026, and $1.1 million in Q4 2025.